Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer
Clinical trial NCT01038752 · TERMINATED
Trial details
- NCT number
- NCT01038752
- Sponsor
- Optimum Therapeutics, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2012-11-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.